Office Action Predictor
Last updated: April 16, 2026
Application No. 18/263,284

CEREBRAL STENT

Non-Final OA §103
Filed
Jul 27, 2023
Examiner
NGUYEN, TUAN VAN
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Intressa Vascular S.A.
OA Round
1 (Non-Final)
82%
Grant Probability
Favorable
1-2
OA Rounds
3y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allow Rate
1006 granted / 1235 resolved
+11.5% vs TC avg
Strong +20% interview lift
Without
With
+19.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
40 currently pending
Career history
1275
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
43.1%
+3.1% vs TC avg
§102
28.0%
-12.0% vs TC avg
§112
17.8%
-22.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1235 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 7 is objected to because of the following informalities: the limitation of “the intermediate layer(s)” in lines 4-5 should be replaced with “the intermediate layer”. Appropriate correction is required. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-6 and 8-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Frid (US 2007/0162104, hereinafter “Frid”) in view of Cattano et al. (US 2013/0218255, hereinafter “Cattano”). Referring to claim 1, Frig discloses an implantable endoluminal prosthesis for use in the treatment of cerebral aneurysm involving branches the prosthesis having a multilayer configuration (Figs. 2-3, 5 and 11; paras. [0082]-[0083]. Fig. 2 is reproduced below) comprising: PNG media_image1.png 266 652 media_image1.png Greyscale at least one self-expandable braided framework 6 (Fig. 2) extending along an axis configured to expand from a radially compressed state in a delivery configuration to a radially expanded state (Paragraph [0019] discloses “In the case of a metal framework, the wires are preferably chosen from among the following materials [Phynox.RTM., Elgiloy.RTM., titanium and its alloys, Nitinol]. After the braiding stage, the metal wires of the stent according to the invention undergo heat treatment to impart them a hardening and a possible phase transition.” Claim 13 discloses “submitting the framework after braiding to a thermical treatment triggering a memory phase transition.” Examiner contends that based on the disclosure above one of ordinary skill in the art will understand that the endoluminal prosthesis of Frig is made from shape memory material to allow the prosthesis to collapse into a compressed state for delivering to the treatment site then transformed into a radially expanded state after the deployment of the prothesis); the self-expandable braided framework being formed by wires (Fig. 2) and devoid of any impermeable cover layer (abstract and claim 1); wherein the self-expandable braided framework comprises a plurality of layers (Fig. 2 shows the framework has three layers 8, 10 and 12; para. [0033]) of wires made of biocompatible material and forms a wall of the endoluminal prosthesis, each of the layers of wires forming a mesh, the meshes forming a lattice with a plurality of the wires of the layers the meshes being interlocked, the wires being integrated in the mesh of at least one adjacent layer (para. [0033] discloses “The framework 6 of the invention is a multiple braid which comprises, in the example shown, three layers 8, 10, 12 whose plies are not distinct: at the time of braiding, a given number of wires 14 of the plies of the first layer 8 are interlaced with the plies of the second layer 10 and/or of the third layer 12, forming a complex lattice (this applies to the figure shown, but it goes without saying that the interlacing can continue to the N.sup.th layer if the number of layers is N).”); wherein the self-expandable braided framework further comprises a lumen in a cylindrical form having a circular cross-section, an axis, and a constant diameter (Figs. 2-3 and 5). Frid discloses the invention substantially as claimed except for disclosing wherein a number of wires crossing a line parallel to the lumen axis in a given layer is higher in an outermost layer than in an innermost layer. However, in the same field of endeavor, which is an endoluminal prosthesis, Cattano discloses the prosthesis includes an inner braid layer 15 and an outer braid layer 14 (FIG. 6b; para. [0108]). Cattano discloses that “In general, it has proven advantageous if one layer 14, has a finer mesh structure than the other layer 15, 14. In other words, one of the two layers 14, 15 can comprise more wires 112, 122 than another layer 14, 15.” (para. [0112]) and “It is particularly preferable if the fine-meshed layer is the outer layer 14 and the wide-meshed layer is the inner layer 15.” (para. [0113]). In view of Cattano’s teaching, it would have been obvious to one of ordinary skill in the art before the effective filling date of the application, to have made the outermost layer of Frid device to have more wires than the innermost layer to deliverrately influencing the blood flow into aneurysm without promoting a degeneration of the muscle cells of the aneurysm wall as suggested by Cattano (para. [0131]). Referring to claim 2, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1 wherein a ratio of the number of wires in the outermost layer to the innermost layer is at least 1.5 (examiner notes that Frid as modified by Cattano will have the condition of the outermost layer has more wire than the innermost layer. In paragraph [0033] Frid discloses the diameter of the wires, the density of the braiding, the number of layers and the number of wires 14 can be adjusted. Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive a ratio of the number of wires in the outermost layer to the innermost layer is at least 1.5 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 3, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the number of wires forming the endoluminal prosthesis is comprised between 50 and 120 (in paragraph [0045] Frid discloses “By adjusting the number of wires, the number of layers and the size of the gaps between the wires, it is possible to obtain the required porosity with the present stent, thus opening up a practical possibility of applying the technique described above.” Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive the number of wires forming the endoluminal prosthesis is comprised between 50 and 120 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 4, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, having a nominal diameter comprised between 3 and 5.5 mm (in paragraph [0034] Frid discloses the stent can be manufactured for small vessel. Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14, diameter of wire 14 and pitch angle of the outer layer and inner layer to derive a prosthesis with a nominal diameter of between 3 and 5.5 mm since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 5, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the wires forming the endoluminal prosthesis have a diameter comprised between 10 and 70 µm. (in paragraph [0021] Frid discloses the wires forming the endoluminal prosthesis have a diameter comprised between 25 and 80 µm. It would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the diameter of wires 14 to derive a diameter of between 10 and 70 µm since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 6, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein a ratio of a surface coverage ratio of the outer layer to a surface coverage ratio of the inner layer is at least 1.5 (examiner notes that Frid as modified by Cattano will have the condition of the outermost layer has more wire than the innermost layer. The number of wire of each layer also directly relate to surface coverage. In other words the outermost layer of Frid/Cattano have more surface coverage than the innermost layer. Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive a ratio of a surface coverage ratio of the outer layer to a surface coverage ratio of the inner layer is at least 1.5 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 8, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the biocompatible material is a metallic substrate selected from the group consisting of titanium, a nickel-titanium alloy, a stainless steel, and a cobalt-chromium-nickel alloy (para. [0019]: “the wires are preferably chosen from among the following materials [Phynox.RTM., Elgiloy.RTM., titanium and its alloys, Nitinol].”). Referring to claim 9, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1 wherein a ratio of the number of wires in the outermost layer to the innermost layer is at least 2 (in paragraph [0033] Frid discloses the diameter of the wires, the density of the braiding, the number of layers and the number of wires 14 can be adjusted. Examiner notes that Frid as modified by Cattano will have the condition of the outermost layer has more wire than the innermost layer. Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive a ratio of the number of wires in the outermost layer to the innermost layer is at least 1.5 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).) Referring to claim 10, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the number of wires forming the endoluminal prosthesis is comprised between 80 and 102. (in paragraph [0045] Frid discloses “By adjusting the number of wires, the number of layers and the size of the gaps between the wires, it is possible to obtain the required porosity with the present stent, thus opening up a practical possibility of applying the technique described above.” Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive the number of wires forming the endoluminal prosthesis is comprised between 80 and 102 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 11, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the number of wires forming the endoluminal prosthesis is less than 100. (in paragraph [0045] Frid discloses “By adjusting the number of wires, the number of layers and the size of the gaps between the wires, it is possible to obtain the required porosity with the present stent, thus opening up a practical possibility of applying the technique described above.” Therefore, it would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the number of wires 14 of the outer layer and inner layer to derive the number of wires forming the endoluminal prosthesis is less than 100 since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 12, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the wires forming the endoluminal prosthesis have a diameter comprised between 20 and 50 µm. (in paragraph [0021] Frid discloses the wires forming the endoluminal prosthesis have a diameter comprised between 25 and 80 µm. It would have been obvious to one of ordinary skill in the art, before the effective filling date of the application, to have perform routing experimentation of the diameter of wires 14 to derive a diameter of between 20 and 50 µm since it has been held that the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine experimentation in the art. In re Antonie, 559 F.2d 618, 195 USPQ 6 (CCPA 1977). MPEP 2145.05 II(B). (In re Aller, 105 USPQ 233).). Referring to claim 13, Frid/Cattano discloses the cerebral implantable endoluminal prosthesis according to claim 1, wherein the wires forming the endoluminal prosthesis have a diameter comprised between 30 and 40 µm. (in paragraph [0021] Frid discloses the wires forming the endoluminal prosthesis have a diameter comprised between 25 and 80 µm). Allowable Subject Matter Claim 7 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TUAN V NGUYEN whose telephone number is (571)272-5962. The examiner can normally be reached Monday - Friday 8:30 AM - 5:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at 571-272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TUAN V NGUYEN/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 27, 2023
Application Filed
Jan 14, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594093
MEDICAL DEVICE CONTROL APPARATUS AND MEDICAL DEVICE
2y 5m to grant Granted Apr 07, 2026
Patent 12588919
THROMBECTOMY DEVICE HAVING CLOT ARRESTOR
2y 5m to grant Granted Mar 31, 2026
Patent 12588925
DEEP VEIN THROMBOSIS THROMBECTOMY DEVICE WITH EMBOLIC PROTECTION
2y 5m to grant Granted Mar 31, 2026
Patent 12588994
DEVICES, SYSTEMS AND METHODS FOR REPAIRING LUMENAL SYSTEMS
2y 5m to grant Granted Mar 31, 2026
Patent 12569273
MEDICAL DEVICE
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
82%
Grant Probability
99%
With Interview (+19.5%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 1235 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month